Lfa Lugano Financial Advisors Sa Biogen Inc. Transaction History

Lfa Lugano Financial Advisors Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $130,589 - $148,801	-509 Reduced 57.84%	371 $103,000
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $222,147 - $269,913	-880 Reduced 50.0%	880 $243,000
Q3 2022 Nov 08, 2022	BUY	$194.69 - $268.46 $171,327 - $236,244	880 Added 100.0%	1,760 $470,000
Q1 2021 Apr 27, 2021	BUY	$242.95 - $284.63 $213,796 - $250,474	880 New	880 $246,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.